Coronary intervention in diabetes: is it different

Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention

“…T here are currently more than 180 million people worldwide with diabetes, and statistics show that the prevalence of diabetes mellitus is increasing worldwide. 1,2 Diabetic patients have an increased risk for cardiovascular )CV( disease, CV morbidity, and mortality due to concomitant metabolic abnormalities. 3 Cardiovascular disease is the leading cause of death in diabetic patients.…”

“…4 In addition, these patients are less likely to benefit from standard treatments for coronary artery disease. 2,5 Diabetes mellitus in patients with acute coronary syndrome )ACS( undergoing percutaneous coronary intervention )PCI( is associated with poor clinical CV outcome and increased mortality. 1 Diabetic ACS patients have poor tolerance for ischemic complications of PCI and short-and long-term ischemic outcome; in addition, major CV events after PCI in diabetic patients is worse than those in nondiabetic patients.…”